Figure 4.
Changes in plasma human immunodeficiency virus (HIV) RNA levels and CD4 counts during valganciclovir therapy. Changes in plasma HIV RNA levels (A) and CD4+ T cell counts (B) were assessed over time in valganciclovir- and placebo-treated participants. Each line represents an individual participant's trajectory. Dark thick lines in panel B represent the estimated mean changes over time within each treatment group from a linear mixed model. There was no evidence for changes over time in either plasma HIV RNA levels or CD4+ T cell counts in either treatment group.